SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia is under pressure after its board opened an independent investigation into CEO Jensen Huangs reported relationship with a businesswoman alleged to have ties to Chinese intelligence. Traders are debating whether the issue poses governance, national-security or leadership risks, while others view the selloff as an overreaction given no confirmed evidence that company secrets were compromised.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

A quarterly revenue shortfall and signs of weaker commercial momentum weighed on sentiment, even as ANKTIVA plus BCG met the primary endpoint in a BCG-naive bladder-cancer trial. Bulls focused on the potential label expansion and broader launch, while skeptics questioned adoption, managements execution, and the risk of future dilution.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Attention centers on the FDAs pending decision on Capricors deramiocel for Duchenne muscular dystrophy, with the amended application focused on preserving upper-limb function and supported in community discussion by HOPE-3 results and a letter from trial investigators. Many traders expect approval and speculate about a short squeeze, while others stress that FDA concerns leave the outcome uncertain and rejection remains a significant risk.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. The firm operates through the following geographical segments: United States and International. It offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Anticipation around Trade Desks quarterly results and guidance is driving discussion after a prolonged share-price slide. Traders are split between hopes that returning co-founder Dave Pickles and high short interest could support a rebound, and concerns about weak growth, execution, and another earnings-related selloff.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics Briumvi-led quarterly revenue beat and higher full-year outlook are driving attention, with traders broadly positive about commercial growth while some question the muted share-price reaction. The Phase 3 readout for subcutaneous Briumvi is seen as the next major catalyst; buyout and short-squeeze talk remains speculative.

Constellation Energy Corp. engages in the generation, supply, and marketing of clean electricity, and renewable energy products and solutions. The firm also offers wholesale energy, retail products and services. It operates under the following geographical segments: Mid-Atlantic, Midwest, New York, Electric Reliability Council of Texas (ERCOT), and Other Power Regions Segment. The company was founded in 1960 and is headquartered in Baltimore, MD.

Constellation Energy Corporation

A stronger-than-expected Q3 report and raised 2026 outlook are driving attention, bolstering the view that AI data-center demand for reliable nuclear power can support growth. Traders largely welcomed the results, while some question the muted share reaction and remain cautious about valuation and whether AI-related demand will translate into durable returns.

NRG Energy, Inc. engages in the production, sale, and distribution of energy and energy services. It operates through the following segments: Texas, East, West/Services/Other, Vivint Smart Home, and Corporate Activities. The Texas segment includes all activities related to customer, plant and market operations in Texas, other than Cottonwood. The East segment engages in all activities related to customer, plant and market operations in the East. The West/Services/Other segment is focused on all activities related to customer, plant and market operations in the West and Canada, and activities related to the Cottonwood facility and other investments. The Vivint Smart Home segment is a smart home platform that provides customers with technology, products and services to create a smarter, greener, safer home. The company was founded in 1989 and is headquartered in Houston, TX.

NRG Energy Inc.

NRG is drawing attention after reporting a strong Q3 and agreeing to sell six gas-fired plants, with proceeds earmarked for buybacks and debt reduction. Traders largely welcomed the results and shareholder-return plans, though some questioned the loss of future earnings from the assets and others voiced bullish expectations for the shares.

XRP (XRP) is a cryptocurrency . XRP has a current supply of 99,985,583,260 with 63,516,606,953 in circulation. The last known price of XRP is 1.11892236 USD and is down -3.62 over the last 24 hours. It is currently trading on 1894 active market(s) with $1,884,610,999.15 traded over the last 24 hours. More information can be found at https://xrpl.org/.

Ripple

XRP is drawing attention amid a broad crypto selloff, with traders linking its slide to Bitcoin weakness and market-wide liquidations. The community is split between expecting further losses and buying or holding the dip, while some also blame uncertainty around crypto regulation.

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

CRISPR Therapeutics AG

CRISPR Therapeutics is drawing attention for clinical updates across its pipeline, especially CTX310 data showing substantial reductions in triglycerides and ANGPTL3, alongside encouraging early zugo-cel results in autoimmune disease. Traders view the readouts as validation of the companys programs, while some question whether early-stage results can drive a lasting share-price revaluation.

Barrick Mining Corp. engages in the production and sale of gold, copper, and related activities. It also provides exploration and mining development. It operates through the following business segments: Carlin, Cortez, Turquoise Ridge, Pueblo Viejo, Loulo-Gounkoto, Kibali, Veladero, North Mara, Bulyanhulu, and Other Mines. The company was founded by Peter D. Munk in 1983 and is headquartered in Toronto, Canada.

Barrick Mining Corp.

Barrick Mining Corp

Barricks earnings miss is weighing on sentiment, though traders also point to stronger production and the Newmont agreement clearing the way for a planned North American asset IPO as positives. The community is split between concerns about execution and the IPO structure and optimism about Barricks gold and copper assets and the broader precious-metals outlook.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Credit Suisse High Yield Credit Fund Announces Preliminary Results of Transferable Rights Offering

Credit Suisse High Yield Credit Fund Announces Preliminary Results of Transferable Rights Offering Credit Suisse High Yield Credit Fund Announces Preliminary Results of Transferable Rights Offering...

Credit Suisse High Yield Credit Fund Announces Transferable Rights Offering

Credit Suisse High Yield Credit Fund Announces Transferable Rights Offering Credit Suisse High Yield Credit Fund Announces Transferable Rights Offering PR Newswire NEW YORK, April 14, 2026 NEW YORK...

Credit Suisse High Yield Bond Fund is a non-diversified, closed-end management investment fund, which engages in seeking high current income investment. It seeks to deliver attractive returns from U.S. high yield bond markets to investors. The firm’s investment strategy is to maximize total return from monetizing macroeconomic themes and exploiting sector and issuer performance and rating dispersion. The company was founded on April 24, 1998 and is headquartered in New York, NY.

UBS Asset Management High Yield Credit Fund

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$16.79
Prev Close	$16.59
Open	$16.57
Dividend Yield	8.90%
50-Day Moving Average	$16.45
Beta	0.34
Avg. Volume	79,313.18
PE Ratio	18.89

52-Week High	$20.70
52-Week Low	$0.026
Market Capitalization	$173.96M
EPS (Annual)	$1.19
Price to Book	0.82
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info

DHY Fundamentals